InterVenn Biosciences: Jason Myers, Carol Berry

Oct 04, 2022

InterVenn Biosciences has appointed Jason Myers and Carol Berry to its board of directors. Myers is CEO of Sequencing Health and was founder, CEO, and a board member at ArcherDx. Berry is senior VP and chief business officer at CellCarta. She was previously senior VP and general manager of the genomics services division at Asuragen.